Making of a dental treatment plan. II. Evaluation of the course.

H. W. Kersten,R. W. Steures,J. M. Trompth

Nederlands Tijdschrift voor Tandheelkunde

Abstract:

What problem does this paper attempt to address?

Immunogenicity and antigenicity of synthetic Escherichia coli lipid A

L Brade,E T Rietschel,S Kusumoto,T Shiba,H Brade

DOI: https://doi.org/10.1128/iai.51.1.110-114.1986

Abstract:The immunogenicity and antigenicity of synthetic Escherichia coli lipid A (compound 506) and its 1- and 4'-monophosphorylated derivatives (compounds 505 and 504, respectively) and nonphosphorylated derivative (compound 503) were compared with those of bis- and 4'-monophosphorylated natural free lipid A from E. coli. The synthetic compounds under study were either coated onto sheep erythrocytes (except for the water-insoluble preparation 503) or incorporated into liposomes and used for the immunization of rabbits. Both types of immunogens (the latter representing fully synthetic immunogens) resulted in high-titered polyclonal antisera which were characterized before or after absorption in a passive hemolysis assay as well as in a passive hemolysis inhibition assay with the synthetic compounds as test antigens. All antisera were found to react with their corresponding homologous antigens coated onto sheep erythrocytes, with titers of up to 2,048, and were comparable to those antisera obtained after immunization with natural lipid A exposed on the bacterial surface after acid hydrolysis. Antisera against bisphosphorylated compound 506 were highly specific for the homologous antigens, showing no interaction with compounds 504 and 505 in the passive hemolysis test. The same held true for the absorption experiments in which glutaraldehyde-fixed sheep erythrocytes were sensitized with the respective antigens. Antisera against monophosphorylated compounds 504 and 505 exhibited, besides their expected homologous reactivity, complete cross-reactivity with compound 506, but they did not cross-react with each other. Thus, anti-504 and anti-505 antibodies recognized distinct antigenic determinants, being related to the ester linked 4'-phosphate or the glycosidically linked 1-phosphate, respectively. Both antigenic determinants were also expressed by bisphosphorylated compound 506 used as an antigen; however, upon immunization, only antibodies against compound 506 were elicited.
Palliative care understanding and end‐of‐life decisions in chronic obstructive pulmonary disease

A. Fahim,J. Kastelik

DOI: https://doi.org/10.1111/crj.12073

2014-07-01

Abstract:Chronic obstructive pulmonary disease (COPD) is one of the leading causes of respiratory morbidity and mortality with limited data on palliative care and evidence of reluctance to end‐of‐life discussions.
Differentiation of Entamoeba Histolytica from E. Dispar Facilitated by Monoclonal Antibodies Against a 150-Kda Surface Antigen

Hiroshi Tachibana,Seiki Kobayashi,Xun-Jia Cheng,Eiji Hiwatashi

DOI: https://doi.org/10.1007/s004360050276

1997-01-01

Parasitology Research

Abstract:Murine monoclonal antibodies (mAbs) were produced against an n-octyl-β-D-glucopyranoside- extracted fraction of trophozoites of Entamoeba histolytica HM-1:IMSS. Four of the mAbs were reactive with a 150-kDa surface antigen characterized by Western-immunoblot analysis under nonreducing conditions. When the reactivity of the four mAbs with nine reference strains of E. histolytica was examined by an indirect fluorescence antibody test, two of the mAbs (EH3015 and EH3023) were found to react with all nine strains and the other two mAbs (EH3056 and EH3126) reacted with seven strains. The four mAbs did not react with any E. dispar reference strain or with other enteric protozoan parasites. The reactivity of EH3015 and EH3023 with numerous isolates of E. histolytica and E. dispar collected in our laboratories was also examined. The 2 mAbs reacted with all of the 37 E. histolytica isolates tested but did not react with any of the 33 isolates of E. dispar. These results indicate that common antigenic epitopes of E. histolytica are on the 150-kDa surface molecule and that mAbs can distinguish between E. histolytica and E. dispar.
Functional Characteristics Of A Protective Monoclonal Antibody Against Serotype A And C Lipooligosaccharides From Moraxella Catarrhalis

WEI-GANG HU,Chen J,McMichael J C,Gu X X

DOI: https://doi.org/10.1128/IAI.69.3.1358-1363.2001

2001-01-01

Infection and Immunity

Abstract:A monoclonal antibody (MAb), designated MAb 8E7 (immunoglobulin G3), specific for Moraxella catarrhalis lipooligosaccharide (LOS) was evaluated for its functional activity in vitro and in a mouse model of colonization. Enzyme-linked immunosorbent assay (ELISA) demonstrated that the MAb 8E7 could be prepared to a high titer against LOS of the homologous strain 035E, and that it had bactericidal activity, MAb 8E7 reacted with M. catarrhalis serotype A and C LOSs but not serotype B LOS, as measured by ELISA and Western blotting. On the basis of published structures of LOSs, this suggests that the epitope recognized by MAb 8E7 is directed to a common sequence of either alpha -GlcNAc-(1-->2)-beta -Glc-(1--> at the branch substituting position 4 of the trisubstituted Glc residue or a terminal tetrasaccharide alpha -Gal-(1-->4)-beta -Gal-(1-->4)-alpha -Glc-(1-->2)-beta -Glc-(1--> at the branch substituting position 6 of the trisubstituted Glc residue. In a whole-cell ELISA, MAb 8E7 reacted with 70% of the 30 wild-type strains and clinical isolates tested. Immune-electron microscopy demonstrated that MAb 8E7 reacted with a cell surface-exposed epitope of LOS on strain O35E, MAb 8E7 inhibited the adherence of strain 035E to Chang conjunctival epithelial cells by 90%. Passive immunization with MAb 8E7 could significantly enhance the clearance of strain O35E from mouse lungs in an aerosol challenge mouse model. This enhanced bacterial clearance was inhibited when MAb 8E7 was absorbed by ill. catarrhalis serotype A LOS, indicating that the M, catarrhalis LOS-directed antibody may play a major role in the enhancement of M. catarrhalis clearance from lungs. These data suggest that MAb 8E7, which recognizes surface-exposed LOS of M. catarrhalis, is a protective antibody against M, catarrhalis.
Analysis of shedding of 3 beta-herpesviruses in saliva from patients with connective tissue diseases.

T. Yoshikawa,M. Ihira,Hiroaki Taguchi,S. Yoshida,Y. Asano

DOI: https://doi.org/10.1086/496890

2005-11-01

Abstract:BACKGROUND Whether an association exists between infection with beta -herpesviruses and connective tissue diseases remains unclear, as are the mechanisms for the regulation of these infections in the salivary glands. METHODS Human herpesvirus (HHV)-7 was isolated and viral DNA was quantified by real-time polymerase chain reaction (PCR) in serially collected saliva samples, to determine whether viral load correlated with infectivity. Then, to examine the role played by beta -herpesviruses in connective tissue diseases, cytomegalovirus, HHV-6, and HHV-7 DNA loads were examined by real-time PCR in serially collected saliva samples from 21 patients with connective tissue diseases. RESULTS Although subjects with frequent HHV-7 shedding were more likely to have a high viral load than were other subjects, high viral loads were detected in saliva samples from a portion of the subjects with low viral shedding rates. No significant difference between the quantity of HHV-7 DNA in saliva samples from which active virus was isolated and that amplified from samples without detectable virus was observed. Patients with adult-onset Still disease consistently had high HHV-7 DNA loads, in contrast to patients with other connective tissue diseases (P=.0003) and healthy adults (P=.0224). The mean HHV-6 (P=.012) and HHV-7 (P<.0001) DNA loads in patients with connective tissue diseases were lower than those in healthy adults. CONCLUSION These data suggest that a number of host factors in patients with adult-onset Still disease may function to accelerate HHV-7 replication in the salivary glands.
Determination of fbe mucosal immunoadjuvantivity of recombinant EschericMa cott LTKA63 mutant and LTB

XIA Xiao-ping,HU Ye,YAN Jie

DOI: https://doi.org/10.3760/j:issn:0254-5101.2006.04.015

2006-01-01

Abstract:To construct the prokaryotic expression systems of detoxified mutant LTKA63 of Es-cherichia coli heat-labile enterotoxin subunit A (LTA) gene and E. coli heat-labile enterotoxin subunit B (LTB) gene, and to determine the mucosal immunoadjuvantivity of the rLTKA63 and rLTB. Methods The LTA and LTB genes from E. coli strain 44815 genome DNA were amplified by high fidelity PCR. Site mutation technique was applied to construct the mutant LTKA63. All the cloned genes were sequenced after T-A cloning. Then the prokaryotic expression systems of LTKA63 and LTB genes were constructed and their expressed products were identified using SDS-PAGE. The pathways activating T lymphocytes of rLTKA63 were determined using the three colors flow cytometry. And GM1-ELISA was used to demonstrate the ability binding bovine GM1 of rLTB. By using recombinant urease subunit B (rU-reB) and adhesin A (rHpaA) as the antigens, the effects of rLTKA63 and rLTB on increasing the immunoprotecrion of rUreB and rHpaA in Helicobacter pylori strain SS1 infected mice were determined respectively. Results The amplification fragments of LTA and LTB genes with expected size were obtained from E. coli strain 44815 genome DNA templates. The mutant LTKA63 with correct sequence was obtained through the site mutation of the cloned LTA gene. The expression outputs of rLTKA63 and rLTB were approximate 30% and 20% of the total bacterial proteins, respectively. After co-incubation with LTKA63, T_H1 and T_H2 lymphocytes were increased by 19.9% and 42.3% respectively. The result of GM1-ELISA indicated that rLTB could combine bovine GM1. 33.3% (4/12) of the gastric biopsy samples in the mice immunized with rUreB alone and 41.7% (5/12) of the gastric biopsy samples in the mice immunized with rHpaA alone were positive for H. pylori isolation, and the rUreB or rHpaA specific S-IgAs in all the animals were negative. When rUreB or rHpaA co-administrated with rLTKA63 or rLTB, the positive H. pylori isolation rates were as lower as 16.7%-25.0% ( P > 0.05) and the rUreB and rHpaA specific S-IgAs positive rates reached 41.6%-58.3% (P<0.01). Conclusion The prokaryotic expression systems of LTKA63 and LTB genes were successfully established in this study. Both the expressed rLTKA63 and rLTB have strong mucosal adjuvant activities.
Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).

R T Coughlin,W C Bogard

DOI: https://doi.org/10.4049/jimmunol.139.2.557

1987-07-15

The Journal of Immunology

Abstract:Abstract The antigen specificity of two immunoprotective monoclonal antibodies derived from mice immunized with Escherichia coli 0111:B4 bacteria and boosted with purified lipopolysaccharide (LPS) were investigated. One of the antibodies, B7, was shown by sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunostaining to bind to the O-antigen containing LPS species, whereas the other antibody, 5B10, reacted with both O-antigen containing homologs and the O-antigen-deficient LPS. 5B10 did not bind to LPS from E. coli J5, an Rc mutant of E. coli 0111:B4 that lacks both the O-antigen and outer core sugars. 5B10 did not cross-react with LPS from several other E. coli strains. Thus 5B10 appeared to recognize a type-specific epitope in the outer core of LPS exclusive of Rc determinants. The monoclonal antibody specific for the polymeric O-antigen is of the IgG3 subclass, and the monoclonal antibody 5B10 specific for the outer core of LPS is an IgG2a. Although B7 and 5B10 were equally able to protect mice from a lethal challenge of E. coli 0111:B4 organisms, the outer core-specific IgG2a antibody was much more efficient at mediating the binding of human complement C3 than the O-antigen-specific IgG3 monoclonal antibody.

immunology
Zinc supplementation in very-low-birth-weight infants.

James Kenneth Friel,W. Andrews,J. D. Matthew,D. Long,Anna M. Cornel,Margaret Cox,E. McKim,Gary O. Zerbe

DOI: https://doi.org/10.1097/00005176-199307000-00015

1993-07-01

Abstract:Inadequate zinc intake may lead to poor growth and developmental outcome in very-low-birth-weight (VLBW; < 1,500 g) infants. Fifty-two infants (mean birth weight, 1,117 +/- 287 g; mean gestational age, 29 +/- 2.9 weeks) were randomly allocated to two groups. SUPP infants received a regular term formula plus zinc supplements (4.4 mg/L; final content, 11 mg/L); PLAC infants received the same formula plus placebo (final content, 6.7 mg/L). Infants started their formula at 1,853 +/- 109 g and consumed the formula for 6 months. All subjects were evaluated at 3, 6, 9, and 12 +/- 0.75 months corrected-for-gestational-age. At each evaluation, weight, length, and head circumference were measured, a Griffiths developmental assessment was performed, and a blood sample was taken. Higher plasma zinc levels (p < 0.05) were found in the SUPP group at 1 and 3 months, and improved linear growth velocity was found in the SUPP group over the study period for the whole group as well as for girls alone. Maximum motor development scores were higher (p = 0.018) in the SUPP (98 +/- 10) than the PLAC (90 +/- 8) group, indicating that increased zinc intake in early infancy may be beneficial to VLBW infants.
Characterization of the Binding Specificity of K88ac and K88ad Fimbriae of Enterotoxigenic Escherichia Coli by Constructing K88ac/K88ad Chimeric FaeG Major Subunits

Weiping Zhang,Ying Fang,David H. Francis

DOI: https://doi.org/10.1128/iai.01165-08

2009-01-01

Infection and Immunity

Abstract:Enterotoxigenic Escherichia coli (ETEC) strains expressing K88 (F4) fimbriae are the major cause of diarrhea in young pigs. Three antigenic variants of K88 fimbriae (K88ab, K88ac, and K88ad) have been identified among porcine ETEC strains. Each K88 fimbrial variant shows a unique pattern in binding to different receptors on porcine enterocytes. Such variant specificity in fimbrial binding is believed to be controlled by the major subunit (FaeG) of the K88 fimbriae, because the genes coding for the only other fimbrial subunit are identical among the three variants. Uniqueness in binding to host receptors may be responsible for differences in the virulence levels of porcine diarrhea disease caused by K88 ETEC strains. To better understand the relationships between the structure of FaeG proteins and fimbrial binding function, and perhaps virulence in disease, we constructed and expressed various K88ac/K88ad faeG gene chimeras and characterized the binding activity of each K88 chimeric fimbria. After verifying biosynthesis of the chimeric fimbriae, we examined their binding specificities in bacterial adherence assays by using porcine brush border vesicles that are specific to either the K88ac or K88ad fimbria. Results showed that each fimbria switched binding specificity to that of the reciprocal type when a peptide comprising amino acids 125 to 163 was exchanged with that of its counterpart. Substitutions of a single amino acid within this region negatively affected the binding capacity of each fimbria. These data indicate that the peptide including amino acids 125 to 163 of the FaeG subunit is essential for K88 variant-specific binding.
The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen.

C. Brooks,Georg Sixta,P. Kosma,T. Hirama,H. Brade,C. Mackenzie,R. Blackler,S. V. Evans,L. Brade,S. Müller-Loennies

DOI: https://doi.org/10.1093/glycob/cwp150

2010-02-01

Glycobiology

Abstract:In order to explore the structural basis for adaptability in near germline monoclonal antibodies (mAb), we have examined the specificity of the promiscuous mAb S67-27 to both naturally derived carbohydrate antigens and a variety of synthetic nonnatural antigens based on the bacterial lipopolysaccharide component 3-deoxy-alpha-D-manno-oct-2-ulosonic acid (Kdo). One such analog, a 7-O-methyl (7-O-Me) Kdo disaccharide, was found to bind to the antibody with at least 30-fold higher affinity than any other antigen tested. The structure of S67-27 in complex with this analog and three other naturally occurring Kdo antigens revealed that the enhanced affinity of the mAb for the synthetic analog was accomplished by the strategic positioning of CDR H3 away from a conserved Kdo binding pocket that allowed the formation of new antibody-antigen contacts. Furthermore, the comparison of this structure with the structures of related mAbs revealed how the position and structure of CDR H3 influence the specificity or promiscuity of near-germline carbohydrate-recognizing antibodies by altering the architecture of the combining site.

Medicine,Biology,Chemistry
Editorial: Therapeutic Advances and their Biomedical Perspectives.

K. Dhama,Y. Malik

DOI: https://doi.org/10.2174/138920021810180105121531

2018-02-28

Current Drug Metabolism

Abstract:
Antigenic crossreactivity and lipopolysaccharide neutralization properties of bovine immunoglobulin G

G M Tomita,D A Todhunter,J S Hogan,K L Smith

DOI: https://doi.org/10.3168/jds.S0022-0302(95)76905-3

Abstract:We investigated a possible mechanism by which immunization against core and lipid A determinants of lipopolysaccharide reduced clinical cases of mastitis and symptoms commonly associated with heterologous Gram-negative IMI. The IgG fraction of sera from cows immunized with either Escherichia coli J5 bacterin, E. coli J5 lipopolysaccharide conjugate vaccine, or unimmunized controls was purified by precipitation with caprylic acid and ammonium sulfate. The degree of IgG crossreactivity with Gram-negative bacteria that were isolated from clinical quarters was greater than that with Gram-positive isolates of Staphylococcus aureus. The highest magnitude of crossreactivity was against smooth strain E. coli isolates, followed by heterologous species of Enterobacter, Serratia, and Klebsiella isolates. Serum IgG from cows immunized with conjugate was highly crossreactive to E. coli J5, E. coli O111:B4, Serratia marcescens, Klebsiella pneumoniae, and Salmonella typhimurium lipopolysaccharides. The magnitude of antibody crossreactivity with lipopolysaccharides coincided with the ability of IgG to suppress the mitogenic effect of lipopolysaccharides on bovine lymphocytes.
Immunochemical studies of conjugates of isomaltosyl oligosaccharides to lipid: production and characterization of mouse hybridoma antibodies specific for stearyl-isomaltosyl oligosaccharides

E Lai,E A Kabat

DOI: https://doi.org/10.1016/0161-5890(85)90105-1

Abstract:Twelve C57BL/6J hybridoma clones, 9, 2 and 1 from mice immunized with stearyl-isomaltotetraose, stearyl-isomaltopentaose and stearyl-isomaltohexaose respectively were characterized. Seven produced IgA and 5 IgM. The specificities and sizes of their combining sites were determined by quantitative precipitin and precipitin inhibition assays. All 12 hybridoma antibodies precipitated with alpha 1----6 dextran B512 and linear dextran LD7, indicating that they recognize an internal -Glc alpha 1----6Glc alpha 1----6Glc- determinant. This in contrast with the results with rabbit antisera obtained in response to the same immunogen which recognize the non-reducing terminal determinant Glc alpha 1----6Glc alpha 1----6Glc-. Of the 12 hybridoma antibodies, 1 has an antibody combining site complementary to 4 alpha 1----6-linked glucoses while others have combining sites complementary to isomaltohexaose or isomaltoheptaose. The large combining-site sizes found in C57BL/6 hybridoma clones may be related to the pre-existing clonal repertoire in this strain. Binding constants of monomers of these antibodies for dextran B512 and isomaltoheptaose determined by affinity electrophoresis range from 1.4 X 10(3) to 4.6 X 10(5) ml/g and from 1.2 X 10(3) to 3.5 X 10(4) M-1 respectively, which is consistent with previous studies in the anti-dextran B512 system. The use of synthetic glycolipids as antigens enables us to study the gene control of antibody responses to glycolipids and to investigate the combining-site specificities of antibodies to a single antigenic determinant. Results so far show that all 12 hybridoma proteins are different despite the simplicity of the antigens. The findings provide further insight into the specificity of antibody combining sites.
Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

R. Saran,Dawn M. Dykstra,R. Wolfe,B. Gillespie,P. Held,E. Young

DOI: https://doi.org/10.1053/AJKD.2002.36895

IF: 11.072

2002-12-01

American Journal of Kidney Diseases

Abstract:BACKGROUND Several drugs have been proposed to improve vascular access patency based on favorable anticoagulant, antiplatelet, or vascular-remodeling properties. However, there is little evidence to guide drug strategies. METHODS The association between vascular access patency and the use of specific drugs was studied in a large sample of US hemodialysis patients enrolled in the Dialysis Outcomes and Practice Patterns Study, an international, prospective, observational study. In general, it was assumed that the drugs were prescribed for indications unrelated to vascular access preservation. Primary (unassisted survival) and secondary vascular access patency (assisted survival) were modeled using Cox regression (time to failure) adjusted for age, sex, race, body mass index, incidence to end-stage renal disease, diabetes mellitus, hypertension, valvular disease, chronic obstructive pulmonary disease, aortic aneurysm, deep-vein thrombosis, number of previous permanent accesses, and facility-clustering effects. Fistulae (n = 900) and grafts (n = 1,944) were evaluated separately. Technical failures within the first 30 days of surgical placement were excluded from the analysis. RESULTS Treatment with calcium channel blockers was associated with improved primary graft patency (relative risk [RR] for failure, 0.86; P = 0.034). Aspirin therapy was associated with better secondary graft patency (RR, 0.70; P < 0.001). Treatment with angiotensin-converting enzyme inhibitors was associated with significantly better secondary fistula patency (RR, 0.56; P = 0.010). Patients administered warfarin showed worse primary graft patency (RR, 1.33; P = 0.037). CONCLUSION These findings should help guide clinical trial priorities toward vascular access preservation using one or more of the agents that show significant risk reduction for access failure in this study.
Physical properties of short- and long-O-antigen-containing fractions of lipopolysaccharide from Escherichia coli 0111:B4

A A Peterson,A Haug,E J McGroarty

DOI: https://doi.org/10.1128/jb.165.1.116-122.1986

IF: 3.2

1986-01-01

Journal of Bacteriology

Abstract:Aggregates of short- and long-chain O-antigen-containing fractions of lipopolysaccharide were analyzed by electron spin resonance probing to reveal differences in their physical properties. The fluidities of the lipid regions of the two fractions were quite similar, although the long-chain lipopolysaccharide aggregates appeared to be more hydrated as reflected by the polarity determined with a lipid probe. In contrast, the head-group region of the long-chain fraction was dramatically more mobile than that of the short-chain sample. The binding of polycations (e.g., polymyxin B, spermine) to lipopolysaccharide aggregates was measured by the partitioning of a cationic spin probe. Less probe was displaced from the long-chain fraction and unseparated lipopolysaccharide than from the short-chain fraction by the addition of cations, suggesting that the long O-antigen masks anionic sites on lipopolysaccharide. These results indicate that the aggregate shape and reactivity of lipopolysaccharide are affected by O-antigen length. Thus, the biological activity of lipopolysaccharide may be modulated directly by the presence of O-antigen and indirectly by the effects of O-antigen on the lipopolysaccharide aggregate structure.

microbiology
Diagnosis and Management of Dry-Eye Syndrome

K. F. Tabbara,M. Wagoner

DOI: https://doi.org/10.1097/00004397-199603620-00008

International Ophthalmology Clinics

Abstract:
Improved Affinity of a Human Anti-Entamoeba Histolytica Gal/GalNAc Lectin Fab Fragment by a Single Amino Acid Modification of the Light Chain.

H Tachibana,N Matsumoto,XJ Cheng,H Tsukamoto,E Yoshihara

DOI: https://doi.org/10.1128/cdli.11.6.1085-1088.2004

2004-01-01

Clinical and Vaccine Immunology

Abstract:ABSTRACTWe previously produced, inEscherichia coli, a human monoclonal antibody Fab fragment, CP33, specific for the galactose- andN-acetyl-d-galactosamine-inhibitable lectin ofEntamoeba histolytica. To prepare antibodies with a higher affinity to the lectin, recombination PCR was used to exchange Ser91and Arg96in the third complementarity-determining region of the light chain with other amino acids. The screening of 200 clones of each exchange by an indirect fluorescent antibody test showed that 14 clones for Ser91and nine clones for Arg96reacted strongly withE. histolyticatrophozoites. Sequence analyses revealed that the substituted amino acids at Ser91were Ala in five clones, Gly in three clones, Pro in two clones, and Val in two clones, while the amino acid at position 96 was substituted with Leu in three clones. The remaining eight clones exhibited no amino acid change at position 91 or 96. These mutant Fab fragments were purified and subjected to a surface plasmon resonance assay to measure the affinity of these proteins to the cysteine-rich domain of lectin. Pro or Gly substitution for Ser91caused an increased affinity of the Fab, but substitution with Ala or Val did not. The replacement of Arg96with Leu did not affect affinity. These results demonstrate that modification of antibody genes by recombination PCR is a useful method for affinity maturation and that amino acid substitution at position 91 yields Fabs with increased affinity for the lectin.
The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E

Simon Brackenridge,Nessy John,Klaus Früh,Persephone Borrow,Andrew J. McMichael

DOI: https://doi.org/10.3389/fimmu.2024.1329032

IF: 7.3

2024-03-21

Frontiers in Immunology

Abstract:The commonly used antibodies 3D12 and 4D12 recognise the human leukocyte antigen E (HLA-E) protein. These antibodies bind distinct epitopes on HLA-E and differ in their ability to bind alleles of the major histocompatibility complex E (MHC-E) proteins of rhesus and cynomolgus macaques. We confirmed that neither antibody cross-reacts with classical HLA alleles, and used hybrids of different MHC-E alleles to map the regions that are critical for their binding. 3D12 recognises a region on the alpha 3 domain, with its specificity for HLA-E resulting from the amino acids present at three key positions (219, 223 and 224) that are unique to HLA-E, while 4D12 binds to the start of the alpha 2 domain, adjacent to the C terminus of the presented peptide. 3D12 staining is increased by incubation of cells at 27°C, and by addition of the canonical signal sequence peptide presented by HLA-E peptide (VL9, VMAPRTLVL). This suggests that 3D12 may bind peptide-free forms of HLA-E, which would be expected to accumulate at the cell surface when cells are incubated at lower temperatures, as well as HLA-E with peptide. Therefore, additional studies are required to determine exactly what forms of HLA-E can be recognised by 3D12. In contrast, while staining with 4D12 was also increased when cells were incubated at 27°C, it was decreased when the VL9 peptide was added. We conclude that 4D12 preferentially binds to peptide-free HLA-E, and, although not suitable for measuring the total cell surface levels of MHC-E, may putatively identify peptide-receptive forms.

immunology
Separation and Characterization of Toxic and Nontoxic Forms of Lipid A

K Takayama,N Qureshi,E Ribi,J L Cantrell,K. Takayama,N. Qureshi,E. Ribi,J. L. Cantrell

DOI: https://doi.org/10.1093/clinids/6.4.439

IF: 20.999

1984-07-01

Clinical Infectious Diseases

Abstract:Highly purified and well-characterized samples of precursors and derivatives of bacterial lipopolysaccharides (LPS) were used to study the relationship between the chemical structure of lipid A and its toxicity. These samples included lipids X and Y (monosaccharide precursors of lipid A) from Escherchia coli MN7; incomplete lipid A (a disaccharide precursor of lipid A) from Salmonella typhimurium i50; and monophosphoryl lipid A, TLC-3 (a derivative of LPS), from S. typhimurium G30/C21. In addition, a diphosphoryl lipid A, TLC-3, was prepared from LPS of S. typhimurium G30/C21 and characterized by positive fast atom bombardment mass spectrometry. The diphosphoryl lipid A, TLC-3 fraction, was determined to be very toxic by the chick embryo lethal-dose test (CELD50 = 0.0064 microgram). Lipids X and Y, incomplete lipid A, and monophosphoryl lipid A (TLC-3), were all nontoxic (CELD50 greater than 10 micrograms). These results suggest a multiple structural requirement for toxicity of lipid A. Toxic lipid A must contain all of the following components: a glucosamine disaccharide, a sugar-1-phosphate, and normal fatty acid(s).

immunology,infectious diseases,microbiology
Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis

Tomohiko OGAWA

DOI: https://doi.org/10.1111/j.1432-1033.1994.tb18552.x

1994-02-01

European Journal of Biochemistry

Abstract:Porphyromonas gingivalis 381 lipid A, characterized by beta-(1-6)-linked glucosamine disaccharide 1-phosphate, with one hydroxyacyl group and one acyloxyacl group, i.e., 3-hydroxy-15-methyl-hexadecanoyl and 3-hexadecanoyloxy-15-methylhexadecanoyl groups at the 2 and 2' positions, respectively, was less endotoxically active than the synthetic Escherichia-coli-type lipid A (compound 506), which possesses beta-(1-6)-linked glucosamine disaccharide 1,4'-bisphosphate, with two acyloxyacyl groups at the 2' and 3' positions and two 3-hydroxytetradecanoyl group at the 2 and 3 positions and the synthetic Salmonella-type lipid A (compound 516), which has three acyloxyacyl groups at the 2,2' and 3' positions and one hydroxyacyl group at the 3 position. P. gingivalis lipid A exhibited no or very low endotoxic activities, i.e., lethal toxicity in galactosamine-loaded mice, preparative ability for local Shwartzman reaction, pyrogenicity and Limulus test as compared with compounds 506 and 516. However, polyclonal B-cell activation of BALB/c mouse splenocytes was as strong as that of compound 506. Furthermore, P. gingivalis lipid A had stronger immunoadjuvant and hemagglutinating activities than compound 506. The absence of ester-linked phosphate at the 4' position and ester-linked fatty acids, and the presence and positions of fatty acids possessing considerable lengths of acyl chains are unique features of P. gingivalis lipid A, and they differentiate this lipid A from enterobacterial and other lipids A. The good balance between endotoxic properties and beneficial immunobiological activities of P. gingivalis lipid A may be attributable to these features.

Making of a dental treatment plan. II. Evaluation of the course.

Immunogenicity and antigenicity of synthetic Escherichia coli lipid A

Palliative care understanding and end‐of‐life decisions in chronic obstructive pulmonary disease

Differentiation of Entamoeba Histolytica from E. Dispar Facilitated by Monoclonal Antibodies Against a 150-Kda Surface Antigen

Functional Characteristics Of A Protective Monoclonal Antibody Against Serotype A And C Lipooligosaccharides From Moraxella Catarrhalis

Analysis of shedding of 3 beta-herpesviruses in saliva from patients with connective tissue diseases.

Determination of fbe mucosal immunoadjuvantivity of recombinant EschericMa cott LTKA63 mutant and LTB

Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).

Zinc supplementation in very-low-birth-weight infants.

Characterization of the Binding Specificity of K88ac and K88ad Fimbriae of Enterotoxigenic Escherichia Coli by Constructing K88ac/K88ad Chimeric FaeG Major Subunits

The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen.

Editorial: Therapeutic Advances and their Biomedical Perspectives.

Antigenic crossreactivity and lipopolysaccharide neutralization properties of bovine immunoglobulin G

Immunochemical studies of conjugates of isomaltosyl oligosaccharides to lipid: production and characterization of mouse hybridoma antibodies specific for stearyl-isomaltosyl oligosaccharides

Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Physical properties of short- and long-O-antigen-containing fractions of lipopolysaccharide from Escherichia coli 0111:B4

Diagnosis and Management of Dry-Eye Syndrome

Improved Affinity of a Human Anti-Entamoeba Histolytica Gal/GalNAc Lectin Fab Fragment by a Single Amino Acid Modification of the Light Chain.

The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E

Separation and Characterization of Toxic and Nontoxic Forms of Lipid A

Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis